Abstract
Currently, humanity is suffering from a highly contagious and infectious novel coronavirus disease. Due to the unavailability of any specifically approved therapy to eradicate this pathogenic virus, day by day, it is claiming more and more lives of humans. Observing the current scenario, human civilization seems to be in dangerous situation, and the development of a potential vaccine against this invisible enemy may take some more time. It was observed that the individual immune system plays an important role in the fight against the novel coronavirus. Additionally, the innate immune system of the host acts as the first line of defense against invading pathogenic viruses. The host innate immune cells can detect and detoxify the evading viruses. Thus, boosting the innate immune response via targeting activator or inhibitory immune check points pathways for enhancing T-cell immune response may potentially help the patients to fight against this deadly virus. The aim of this editorial is to discuss in brief about the pathogenesis of COVID-19, the role of innate immunity and autophagy during viral clearance.
Keywords: COVID-19, convalescent plasma therapy, innate immunity, novel coronavirus, SARS-CoV-2, pathogenesis of COVID.
Coronaviruses
Title:Boosting Innate Immunity During SARS-CoV-2 Clearance
Volume: 2 Issue: 8
Author(s): Abhishesh Kumar Mehata*, Deepa Dehari, Anuj Kumar Mehta and Alim Miya
Affiliation:
- Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi– 221005,India
Keywords: COVID-19, convalescent plasma therapy, innate immunity, novel coronavirus, SARS-CoV-2, pathogenesis of COVID.
Abstract: Currently, humanity is suffering from a highly contagious and infectious novel coronavirus disease. Due to the unavailability of any specifically approved therapy to eradicate this pathogenic virus, day by day, it is claiming more and more lives of humans. Observing the current scenario, human civilization seems to be in dangerous situation, and the development of a potential vaccine against this invisible enemy may take some more time. It was observed that the individual immune system plays an important role in the fight against the novel coronavirus. Additionally, the innate immune system of the host acts as the first line of defense against invading pathogenic viruses. The host innate immune cells can detect and detoxify the evading viruses. Thus, boosting the innate immune response via targeting activator or inhibitory immune check points pathways for enhancing T-cell immune response may potentially help the patients to fight against this deadly virus. The aim of this editorial is to discuss in brief about the pathogenesis of COVID-19, the role of innate immunity and autophagy during viral clearance.
Export Options
About this article
Cite this article as:
Mehata Kumar Abhishesh*, Dehari Deepa , Mehta Kumar Anuj and Miya Alim , Boosting Innate Immunity During SARS-CoV-2 Clearance, Coronaviruses 2021; 2 (8) : e260721189347 . https://dx.doi.org/10.2174/2666796701999201222113659
DOI https://dx.doi.org/10.2174/2666796701999201222113659 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Analysis of Drug Repositioning and Prediction Techniques: A Concise
Review
Current Topics in Medicinal Chemistry Therapeutic Approaches for Combating <i>Aspergillus</i> Associated Infection
Current Drug Targets Drug Design for Neglected Disease in Brazil
Mini-Reviews in Medicinal Chemistry Comparative QSAR Studies on the Novel Series of Thiazolones and Tetrazole Derivatives as HCV NS5B Polymerase Allosteric Inhibitors
Letters in Drug Design & Discovery Synthesis and Anticancer Evaluation of Sulfur Containing 9-anilinoacridines
Recent Patents on Anti-Cancer Drug Discovery Recent Developments in Phytosterol Recovery from Oil Deodorizer Distillates
Current Nutrition & Food Science Inhibition of Protein Tyrosine Phosphatase 1B as a Potential Treatment of Diabetes and Obesity
Current Pharmaceutical Design Relevance of Aromatase Inhibitors in Breast Cancer Treatment
Current Topics in Medicinal Chemistry Innate and Adaptive Immune Responses in Allergic Contact Dermatitis and Autoimmune Skin Diseases
Inflammation & Allergy - Drug Targets (Discontinued) Coagulopathy and COVID-19
Current Drug Targets New Coronavirus Outbreak
Current Pharmaceutical Analysis Glycine/NMDA Receptor Antagonists as Potential CNS Therapeutic Agents: ACEA-1021 and Related Compounds
Current Topics in Medicinal Chemistry Recent Approaches to Novel Antibacterials Designed After LPS Structure and Biochemistry
Current Drug Targets Anaphylaxis in Risky Populations
Current Pharmaceutical Design On The Edge of Validation – Cancer Protease Fibroblast Activation Protein
Mini-Reviews in Medicinal Chemistry Green Tea Extract-Patents and Diversity of Uses
Recent Patents on Food, Nutrition & Agriculture NPC1 as a Modulator of Disease Severity and Viral Entry of SARSCoV- 2
Current Molecular Medicine Ethnobotany, Pharmacological Activities and Bioavailability Studies on “King of Bitters” (Kalmegh): A Review (2010-2020)
Combinatorial Chemistry & High Throughput Screening Studies on α-Glucosidase Inhibitors Development: Magic Molecules for the Treatment of Carbohydrate Mediated Diseases
Mini-Reviews in Medicinal Chemistry Prion Chemical Biology: On the Road to Therapeutics?
Current Topics in Medicinal Chemistry